Flint, Janna <br/><br/>
Relationships between osteoprotegerin (OPG), receptor activator of nuclear factor kappaB ligand (RANKL), and growth hormone (GH) secretory status in short children.  [electronic resource] 

 -  Journal of pediatric endocrinology & metabolism : JPEM  Dec 2009 
 - 1105-12 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0334-018X 
<br/><br/><label>Standard No.: </label>10.1515/jpem.2009.22.12.1105  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorptiometry, Photon<br/>Adolescent<br/>Body Height<br/>Bone Density<br/>Bone Development--physiology<br/>Child<br/>Child, Preschool<br/>Female<br/>Human Growth Hormone--blood<br/>Humans<br/>Infant<br/>Insulin-Like Growth Factor Binding Protein 3<br/>Insulin-Like Growth Factor Binding Proteins--blood<br/>Insulin-Like Growth Factor I--metabolism<br/>Male<br/>NF-kappa B--metabolism<br/>Osteoprotegerin--blood<br/>Predictive Value of Tests<br/>RANK Ligand--blood<br/>Regression Analysis